Winton Group’s AngioDynamics ANGO Stock Holding History

Winton Group’s Portfolio ANGO Stock Details ANGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-39,540	Closed	-$310K	–	600
2023 Q4	$310K	Buy	+39,540	New	+$274K	0.02%	530
2021 Q3	–	Sell	-10,058	Closed	-$273K	–	1324
2021 Q2	$273K	Sell	10,058 -3,600	-26%	-$87.9K	0.01%	1228
2021 Q1	$320K	Sell	13,658 -2,236	-14%	-$45.2K	0.02%	1118
2020 Q4	$244K	Buy	+15,894	New	+$202K	0.02%	1122
2020 Q2	–	Sell	-63,111	Closed	-$658K	–	1442
2020 Q1	$658K	Sell	63,111 -54,809	-46%	-$688K	0.02%	953
2019 Q4	$1.89M	Buy	117,920 +63,920	+118%	+$976K	0.03%	823
2019 Q3	$995K	Buy	54,000 +36,331	+206%	+$711K	0.01%	830
2019 Q2	$348K	Buy	17,669 +2,786	+19%	+$56.7K	0.01%	828
2019 Q1	$340K	Buy	+14,883	New	+$323K	0.01%	752
2018 Q4	–	Sell	-70,286	Closed	-$1.53M	–	858
2018 Q3	$1.53M	Buy	+70,286	New	+$1.56M	0.03%	333

Other funds holding ANGO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SFM

Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

PCMI

Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Winton Group's ANGO Position: Q1 2024 in Review

Winton Group sold out of AngioDynamics (ANGO) in Q1 2024, closing a stake of 39,540 shares — an estimated $310K sold.

Winton Group first reported a position in ANGO in Q3 2018 and held it in 10 quarters. The position peaked at $1.89M in Q4 2019. 135 funds tracked by Wall St. Rank hold ANGO as of Q1 2024.

Winton Group reported no remaining AngioDynamics position as of Q1 2024 after selling out during the quarter.
Winton Group sold 39,540 AngioDynamics shares in Q1 2024, an estimated $310K.
Winton Group first reported a position in AngioDynamics in Q3 2018 and held it in 10 quarters.
Winton Group's AngioDynamics position peaked at $1.89M in Q4 2019.
135 funds tracked by Wall St. Rank held AngioDynamics as of Q1 2024.

Based on Winton Group's 13F filing for Q1 2024, filed 14 May 2024.